Join the club for FREE to access the whole archive and other member benefits.

Adam Feuerstein

Senior Writer at stat news

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. A veteran journalist, Adam was Senior Columnist at TheStreet, where he wrote about biotech and drug stocks.

Visit website: https://www.statnews.com/staff/adam-feuerstein/

 adam-feuerstein-7a8a7713

 adamfeuerstein

See also: Publisher STAT - Media company focussed on health, medicine, and scientific discovery

Details last updated 07-Dec-2020

Articles written by Adam Feuerstein

CRISPR's gene editing therapy finds cure for blood cancer

CRISPR's gene editing therapy finds cure for blood cancer

STAT - 05-Dec-2020

Early data from Vertex & CRISPR showed promising results to cure blood disorders